Konstantinos Kalogeropoulos is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), leading research at the Cell Diversity Lab. His work bridges proteomics, computational biology, and snake venom research. Current projects: "The Proteomic Landscape during Influenza Infection" (2022-2025) Supervisor for PhD projects on protease network rewiring in psoriasis and wound exudate degradomics Research interests include: Proteomic analysis of inflammatory diseases Snake venom toxin structure prediction Extracellular matrix biomechanics De novo peptide sequencing algorithms Computational modeling of protease networks Recent article trends demonstrate his work in • Database-free proteomics (InstaNovo/InstaNexus) • Snake venom pathophysiology (V-ToCs clustering) • Inflammatory disease biomarkers (psoriasis, impaired healing) • Extracellular matrix mechanics (fibronectin tension, gut inflammation) Advising: Supervises PhD students Polhaus, C. J. M. and Haack, A. M., focusing on protease networks and wound healing.
Professor David E. Gloriam is a leading expert in G protein-coupled receptors (GPCRs) at the University of Copenhagen , Department of Drug Design and Pharmacology. Recognized as a top 1% Clarivate Highly Cited Researcher, he leads GPCRdb, a major database with >50,000 annual users, and develops computational tools like GPCRgraphs for drug discovery. His innovation roles include Senior Scientific Expert at Kvantify A/S and applications in pharmaceutical industry tools with patent citations. Education: Ph.D. in Medicine (Uppsala University, 2006), M.Sc. in Pharmaceutical Sciences (Uppsala University, 2003) Leadership: Head of GPCRdb (2014–), EU COST Actions member (2014–17), and institutional leadership roles in Pharmaceutical Data Science unit and Research Leadership Forum Research Interests: His work spans computational modeling of GPCR dynamics, virtual screening methods for inaccessible receptors, pharmacogenomics (PGxDB platform), and biased signaling for safer drugs. He integrates structural biology, data science, and bioinformatics to advance pharmaceutical discovery. Awards: Clarivate Highly Cited Researcher (2022) IUPHAR Analytical Pharmacology Award (2023) Lars Arge Prize for Big Data (2021) UCPH Forward Talent Program (2019) ERC Starting Grant (2014) Teaching & Supervision: Teaches Molecular Pharmacology and AI in Drug Discovery , and supervises 3 current PhD students. He has mentored 13 PhDs and 14 Postdocs, with former members attaining tenured academic or industry roles.
Professor Selin Kara is affiliated with the Department of Biological and Chemical Engineering at Aarhus University, Faculty of Engineering. Her primary research focuses on Industrial Biotechnology, Biocatalysis, and Process Intensification, with expertise in Enzyme Immobilisation and Sustainable Process Engineering. She leads projects exploring novel biocatalytic processes, non-conventional reaction media, and the optimization of enzymatic reactions for industrial applications. Her research integrates experimental and computational approaches to enhance enzyme performance in non-aqueous solvents like deep eutectic solvents (DES) and lipid-based systems. Projects include developing photocatalytic synthesis methods, fusion enzymes for enzymatic cascades, and novel hydrogel characterization techniques. She has contributed to advancing light-driven sustainable biocatalysis and improving antimicrobial biomaterials. Key projects include the PHOTOX-f initiative (2025) and PhotoBioCat network (2018-2022), focusing on light-dependent biocatalytic systems and sustainable chemical production. Her work emphasizes industrial applications, environmental impact analysis, and process optimization for scalable biocatalytic solutions. Award-winning educator and researcher, Professor Kara collaborates internationally and holds a prominent role in training early-stage researchers in sustainable biocatalysis through EU-funded networks. Her labs specialize in enzymatic process development, material characterization, and continuous flow bioreactors.
Amelie Stein is an Associate Professor at the Department of Biology, University of Copenhagen, specializing in Bioinformatics and RNA Biology. Her research focuses on protein stability, molecular mechanisms of disease variants, and computational methods for protein design. She is affiliated with the UCPH Quantum Hub, reflecting interdisciplinary interests in biological systems. Her work integrates bioinformatics tools, mutational scanning, and structural biology to understand protein degradation pathways and their relevance to human diseases such as Lynch syndrome and metabolic disorders. Key research areas include analyzing protein variants using deep learning models (e.g., SSEmb), developing web-based tools like MutationExplorer for 3D visualization, and characterizing disease-linked mutations in proteins such as Parkin and MLH1. Her publications highlight breakthroughs in rapid protein stability predictions, degon mapping, and the interplay between protein toxicity and degradation. No scientific awards are explicitly mentioned in the provided texts. Stein’s research also explores the application of computational approaches to biotechnology and therapeutic development, emphasizing translational applications of her findings. Her lab, linked to the SCARB research group (https://www1.bio.ku.dk/english/research/scarb/), focuses on structural and computational biology, with ongoing projects involving protein quality control networks and enzyme variant analysis. Collaborations span molecular biology, bioinformatics, and interdisciplinary quantum-related research through her UCPH Quantum Hub membership.
Kasper Harpsøe is a Research Consultant and Data and Computing Facility Manager at the Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen. He has extensive expertise in computational medicinal chemistry with over 15 years of experience in molecular modeling techniques, particularly focused on G Protein-Coupled Receptors (GPCRs). Harpsøe earned his Ph.D. in Computational Chemistry from The Danish University of Pharmaceutical Sciences in 2006 with research on "Computational Studies on the Allosteric Modulation of AMPA Receptors." He holds a Master of Science in Pharmacy (Cand. Pharm.) from The Royal Danish School of Pharmacy completed in 2001. His international experience includes a three-month traineeship at Schrödinger Inc. in New York and research collaboration with the Carlson group at the University of Michigan. His research expertise spans structure-based design of peptide and small molecule ligands, binding site identification, docking and binding pose evaluation, protein-ligand interactions, conformational analysis, QSAR, sequence analysis, homology modeling, molecular dynamics, and quantum chemistry calculations. Harpsøe has made significant contributions to understanding GPCR structure-function relationships, ligand recognition mechanisms, and G protein coupling specificity. Analysis of his publication record reveals a consistent focus on GPCR molecular pharmacology, with particular emphasis on serotonin receptors, orphan receptors like GPR139, and GABA receptors. His work integrates computational approaches with experimental validation to identify molecular determinants of receptor selectivity and to design novel ligands for therapeutic applications. The research bridges structural biology, molecular modeling, and medicinal chemistry in the context of drug discovery. Harpsøe currently manages the department's Data and Computing Facility, overseeing a GPU Linux cluster and providing computational support for research groups. Previously, from 2014 to 2021, he served as project manager for computational drug design activities within the Gloriam Group, working on multidisciplinary drug discovery projects in collaboration with medicinal chemists, molecular pharmacologists, structural biologists, and data scientists from both academia and industry.
Trond Ulven is a Professor of Medicinal Chemistry at the Department of Drug Design and Pharmacology, University of Copenhagen since January 2018. Previously, he served as Professor at the University of Southern Denmark from 2012-2018, holding positions with special responsibilities in entrepreneurship. He is also the Director and co-founder of Caldan Therapeutics since 2015, demonstrating his commitment to translational research. His educational background includes: Doctor engineer (dr.ing.) of Organic Chemistry, Norwegian University of Science and Technology (NTNU), 1999 Civil engineer (siv.ing.) of Organic Chemistry, Norwegian Institute of Technology (NTH), 1994 Examen philosophicum, University of Trondheim, Norway, 1992 Professor Ulven's research focuses on medicinal chemistry and drug discovery, particularly targeting G protein-coupled 7-transmembrane receptors (GPCRs). His work emphasizes free fatty acid receptors, which show significant potential as drug targets for metabolic diseases. His research also extends to chemokine receptors and AMPK signaling within inflammation and metabolic disease contexts. His group develops synthetic methods to support structure-activity relationship studies and efficient compound identification, with continuous efforts to create simpler, more efficient, and greener synthetic approaches. His extensive publication record (162 research outputs) demonstrates consistent productivity and relevance in the field. The research trends show a deep focus on GPCR pharmacology, particularly free fatty acid receptors (FFAR1, FFAR2, FFAR4) and GPR84. His work spans molecular pharmacology, medicinal chemistry optimization, and translational studies examining metabolic effects in animal models, integrating biochemical, cellular, and in vivo approaches to understand receptor function and develop therapeutic compounds. Professor Ulven maintains an active research laboratory with significant industry connections through Caldan Therapeutics. His work has garnered attention across multiple platforms including X (formerly Twitter), Facebook, Bluesky, and news outlets, indicating impact within both scientific and broader communities. His research has practical applications in metabolic disease therapeutics, with publications appearing in high-impact journals including Nature, Nature Communications, Science Advances, and Journal of Medicinal Chemistry.
Frederikke Isa Marin is a Research Fellow in the Machine Learning section at the Department of Computer Science, University of Copenhagen. Her research focuses on the intersection of machine learning and biological applications, particularly in protein engineering, DNA language modeling, and computational biology. Her primary research interests include developing machine learning frameworks for biological sequence analysis, protein stability prediction, computational protein design, and benchmarking methodologies for DNA language models. She employs generative models, deep learning, and computational simulations to address challenges in structural biology and genomics. Marin's recent publications demonstrate a strong focus on applying machine learning to biological systems. Her work spans protein engineering (including thioredoxin fold redesign and thermal stability prediction), DNA language model benchmarking (BEND), immune receptor modeling, and predictive methods for peptide functionality. Her research consistently combines computational approaches with experimental validation. She maintains collaborative relationships within the Machine Learning section and contributes to the university's computational biology initiatives. Her work utilizes departmental compute resources and aligns with the research groups focused on biological applications of AI.
Jeppe Kari is an Associate Professor in the Department of Science and Environment Chemistry at Roskilde University. His research focuses on biophysical chemistry, particularly biocatalysis and interfacial enzyme kinetics. He aims to bridge inorganic heterogeneous catalysis and biocatalysis to advance heterogeneous biocatalysis as a field. His work emphasizes understanding enzyme behavior at solid-liquid interfaces and optimizing enzyme systems for industrial applications. Key research areas include enzymatic hydrolysis of cellulose, Sabatier principle applications, and computational methods for predicting enzyme activity. Collaborations span international institutions, as indicated by his network of external research partners. His publications highlight advancements in enzyme kinetics modeling, substrate interactions, and enzyme engineering. Notable contributions include studies on cellulase efficiency limitations, ITC analysis of polydisperse systems, and virtual bioprospecting of interfacial enzymes. Kari’s lab integrates computational and experimental approaches to address challenges in biocatalytic processes. Education: Holds an MSc and PhD in relevant fields (specific institutions not detailed in text). No awards or grants explicitly listed. Advises on projects related to cellulase optimization and enzyme kinetics. Maintains a research website at www.jeppekari.com .
Claus Juul Løland is an Associate Professor in the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on neuropharmacology, particularly examining the biochemical effects of substances like cocaine and amphetamines in the brain, addiction mechanisms, and the dopamine reward system. Position: Associate Professor Institution: University of Copenhagen Department: Department of Neuroscience Research Group: Neuropharm and Genetics Location: Blegdamsvej 3B, 2200 Copenhagen N Løland's primary research interests center on understanding drug addiction mechanisms, particularly related to cocaine and amphetamines, with specific expertise in the dopamine transporter system. His work investigates how these substances interact with brain chemistry to produce addictive behaviors, including research on smoking addiction and the dopamine reward system. His laboratory employs advanced biochemical and structural biology techniques to study neurotransmitter transporters at the molecular level. Analysis of his recent publications (2024-2025) reveals a strong focus on membrane protein biochemistry, particularly neurotransmitter transporters. His work combines structural biology approaches (including NMR spectroscopy) with medicinal chemistry to understand how psychoactive substances like cocaine interact with their molecular targets. A significant portion of his recent work involves developing novel detergents for membrane protein stabilization, which is crucial for structural studies of neurotransmitter transporters. Løland leads the Løland-lab at the University of Copenhagen, which maintains an active research program with numerous international collaborations. His work has been featured in major media outlets including TV2 Nyhederne and other Danish news media, particularly around breakthroughs in understanding cocaine's mechanism of action in the brain.
Johan Gotthardt Olsen serves as Assistant Professor and Guest Researcher in the Department of Biology within the Faculty of Science at the University of Copenhagen. His research focuses on the structural and dynamic properties of proteins, particularly intrinsically disordered systems and their biological functions. His primary research interests center on protein conformational dynamics, molecular recognition mechanisms, and the biophysical principles governing intrinsically disordered proteins. Olsen investigates how structural transitions in proteins regulate cellular processes like DNA replication, signal transduction, and enzyme activation, employing techniques spanning NMR spectroscopy, computational modeling, and biophysical characterization. Analysis of his recent publications (2021-2025) reveals a consistent research trajectory examining protein disorder-order transitions, with particular emphasis on molecular recognition in DNA-protein interactions and enzyme regulation. His work frequently combines experimental and computational approaches, resulting in publications in high-impact journals including Nature, Journal of the American Chemical Society, and Nucleic Acids Research. Olsen maintains active collaborations with multiple research groups, particularly with Professor Birthe B. Kragelund's team, as evidenced by co-authorship patterns across his publications. His research group participates in interdisciplinary projects bridging biochemistry, biophysics, and molecular biology, focusing on fundamental mechanisms with potential implications for drug discovery and disease understanding.
Godefroid Charbon is an Associate Professor in the Department of Biology at the University of Copenhagen, specializing in Functional Genomics. His research primarily focuses on bacterial chromosome replication mechanisms, antimicrobial resistance, and developing novel peptide-based antimicrobial strategies that minimize resistance development. Based at Ole Maaløes Vej 5 in Copenhagen, he maintains an active research program with extensive collaboration networks. Dr. Charbon's research centers on the molecular mechanisms of bacterial chromosome replication, particularly in Escherichia coli and Staphylococcus aureus . His work investigates the DnaA protein's critical role in replication initiation, cell cycle control, and how bacteria regulate DNA synthesis. A significant portion of his research focuses on developing peptide-nucleic acid conjugates that target essential replication proteins, creating antimicrobial approaches with reduced resistance potential. His functional genomics work examines bacterial responses to replication stress and antimicrobial challenges, with implications for understanding fundamental bacterial physiology and developing next-generation therapeutics. Analysis of Dr. Charbon's publication record reveals a consistent focus on bacterial replication mechanisms and antimicrobial development over the past five years. His research demonstrates expertise in molecular genetics, bacterial physiology, and antimicrobial discovery, with particular emphasis on overcoming antibiotic resistance mechanisms. The work spans from fundamental studies of replication initiation to applied research on novel antimicrobial compounds, showing strong translational potential. His frequent collaborations with Løbner-Olesen and others highlight interdisciplinary approaches combining molecular biology, genetics, and pharmaceutical sciences to address complex challenges in bacterial pathogenesis. Dr. Charbon maintains active research collaborations across multiple institutions, as evidenced by his extensive publication record totaling 35 research outputs. His work has generated significant academic interest, with multiple publications appearing in high-impact journals and receiving attention across academic platforms including Mendeley, X (Twitter), and Bluesky. His research program demonstrates strong continuity with publications spanning from 2021 through 2025, indicating an active and productive academic career trajectory at the University of Copenhagen.
Thomas Günther-Pomorski serves as Full Professor at Ruhr-University Bochum and holds a part-time position at the University of Copenhagen's Department of Plant and Environmental Sciences (Section for Transport Biology). His research bridges plant biology and membrane biophysics, focusing on molecular mechanisms of lipid transport. His primary research interests include: Biophysical characterization of membrane proteins Function and dynamics of P4 ATPases in vesicular transport Molecular analysis of P-type ATPases ABC protein roles in sterol transport Plant plasma membrane H⁺-ATPase mechanisms Recent publications (2023-2025) demonstrate advanced methodologies including single-vesicle analysis , fluorescence-based flippase assays , and giant unilamellar vesicle reconstitution . Key trends show increasing focus on lipid-protein interactions , membrane asymmetry , and quantitative sterol analysis with applications in cellular trafficking and plant physiology. Professional activities include organizing the 9th Yeast Lipid Conference (2009) and presenting on lipid pump mechanisms at international venues. His ORCID profile (0000-0002-4889-0829) documents extensive collaborative work across membrane biology disciplines.
Kamilla Woznica Miskowiak is a Professor of Cognitive Neuropsychiatry and Clinical Professor in the Department of Clinical Medicine and Department of Psychology at the University of Copenhagen. She serves as head of the Neurocognition and Emotion in Affective Disorders (NEAD) Centre at the Mental Health Services, Capital Region of Denmark, and the Department of Psychology, University of Copenhagen. Her educational background includes: DPhil in Experimental Psychology and Psychiatry from the University of Oxford (2005-2008) Master of Science in Psychology from the University of Copenhagen (2004-2006), where she received a gold medal for her dissertation "Neuropsychological Research on Depression - Towards a Synergy between Cognitive and Neurobiological Theories and Methods" Master of Science (Distinction) in Experimental Psychology from the University of Oxford (2003-2004) Professor Miskowiak's research focuses on cognitive neuropsychiatry, with particular emphasis on identifying cognitive and neuroimaging biomarkers for depression and bipolar disorder. Her work involves developing and clinically testing new interventions for cognitive impairment in neuropsychiatric disorders and delineating the neurocognitive and brain-based mechanisms of biological and psychological treatments for mood disorders. She leads multidisciplinary research that aims to improve understanding, prevention, and treatment of cognitive impairment and affective disorders. Her recent publications demonstrate a strong focus on cognitive aspects of mood disorders, particularly bipolar disorder, with research spanning biomarker identification, cognitive assessment methods, and the relationship between cognitive function and clinical outcomes. Her work often employs advanced methodologies including neuroimaging and virtual reality assessment tools. Professor Miskowiak supervises Master's theses and PhD students within cognitive neuropsychiatry and offers postgraduate courses in Cognitive Neuropsychiatry and Clinical Neuropsychology. She maintains office hours on Tuesdays from 12:00-13:00. She heads the NEAD Centre, which has strong national and international collaborations with the Neurobiological Research Unit at Rigshospitalet, as well as research groups at Harvard University, University of Oxford, and the Max Planck Institute. The Centre's work spans four main areas: identifying neurocognitive biomarkers, developing screening tools, creating new treatments targeting cognitive impairment, and elucidating mechanisms of existing and experimental treatments.
Caio de Oliveira Gorgulho Silva is a Research Fellow at the Section for Protein Chemistry and Enzyme Technology , part of the Department of Biotechnology and Biomedicine at the Technical University of Denmark (DTU). His work focuses on enzyme biotechnology, particularly polyphenol oxidases and their role in lignin biodegradation and biomass valorization. He actively supervises PhD students in computational studies of glycosyltransferases and polyphenol oxidases, contributing to advanced research in enzyme mechanisms and applications. Research Focus: Enzyme structure-function relationships Key Areas: Lignin biotechnology, fungal interactomics Scientific Collaborations: His projects highlight collaborations across Denmark and internationally, emphasizing interdisciplinary approaches to enzyme engineering and sustainable bioprocessing. Current work includes unspecific peroxygenases' oxidative activity towards lignin and computational studies of enzyme families.
Carsten Jers is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark (DTU), specializing in bacterial signal transduction and enzyme engineering. His work contributes to multiple UN Sustainable Development Goals through biosustainability research. As part of the DTU Microbes Initiative, he maintains an active research profile with 44 publications and involvement in 9 research projects. Dr. Jers' research focuses on enzyme biochemistry, molecular biology, and microbiology, with particular expertise in sialidase/neuraminidase studies, protein phosphorylation mechanisms, and thermostability of enzymes. His fingerprint analysis reveals strong connections to Escherichia coli research (85%), thermostability studies (55%), protein phosphorylation (49%), and human milk oligosaccharide research (47%). His recent publications demonstrate a strong trend in enzyme engineering for industrial applications, genomic analysis of bacterial pathogens (particularly Enterococcus species), and development of bacterial systems for protein production. His work bridges fundamental molecular mechanisms with practical applications in food safety, biocatalysis, and sustainable bioproduction. Dr. Jers actively supervises multiple PhD students through the Novo Nordisk Foundation Center for Biosustainability, with current projects focusing on bacterial cell engineering, pathogen proteomics, and microbiome analysis. His research has gained significant attention, with publications mentioned by news outlets, blogged about, and shared across social media platforms including X (Twitter) and Facebook. His laboratory work centers on bacterial signal transduction mechanisms, with particular focus on developing engineered bacterial systems for industrial applications, studying microbial safety profiles, and exploring thermostable enzymes from extremophiles for biocatalytic processes.
